Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
MorphoSys has said it its Phase 3 test of pelabresib will have preliminary data in early 2024.
Roche, in partnership with MorphoSys, is working on the development and potential commercialization of gantenerumab, a monoclonal antibody for the treatment of Alzheimer's.